Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director

/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced its Board of Directors has appointed a new...

Related Keywords

Eli Lilly ,Carol Gallagher ,Vanderbilt University ,Anadys Pharmaceuticals ,Gilead Sciences ,Board Of Trustees For The Salk Institute ,Pfizer ,Bristol Myers Squibb ,Twitter ,Amgen ,Exchange Commission ,Mirati Therapeutics Inc ,Agouron Pharmaceuticals ,Nasdaq ,Enterprise Associates ,Facebook ,Prnewswire Mirati Therapeutics Inc ,University Of Kentucky ,Linkedin ,Calistoga Pharmaceuticals ,David Meek ,Mirati Therapeutics ,New Enterprise Associates ,Idec Pharmaceutics ,Turning Point ,Emirati Board ,Nc ,